Mycobacterium Citations List: October 2022

Literature Citations

1. Synthesis, Characterization, Anti-mycobacterial Activity and in Silico Study of New 2,5-Disubstituted-1,3,4-oxadiazole Derivatives. Azmi, M.N., N.S. Hasmaruddin, N.A. Mat Ali, H. Osman, S. Mohamad, T. Parumasivam, M.Z. Hassan, M.S. Abd Ghani, and K. Awang. Tropical Biomedicine, 2022. 39(3): p. 467-475. PMID[36214446].
[PubMed]. TB_10_2022.

2. Synthesis and Structure-Activity Relationship Studies of Pyrido [1,2-e]purine-2,4(1H,3H)-dione Derivatives Targeting Flavin-dependent Thymidylate synthase in Mycobacterium tuberculosis. Biteau, N.G., V. Roy, C. Nicolas, H.F. Becker, J.C. Lambry, H. Myllykallio, and L.A. Agrofoglio. Molecules, 2022. 27(19). PMID[36234754]. PMCID[PMC9571937].
[PubMed]. TB_10_2022.

3. A Hydrazine-hydrazone adamantine Compound Shows Antimycobacterial Activity and Is a Probable Inhibitor of Mmpl3. Briffotaux, J., Y. Xu, W. Huang, Z. Hui, X. Wang, B. Gicquel, and S. Liu. Molecules, 2022. 27(20). PMID[36296721]. PMCID[PMC9610904].
[PubMed]. TB_10_2022.

4. Synthesis, Anticancer and Antitubercular Properties of New Chalcones and Their Nitrogen-containing Five-membered Heterocyclic Hybrids Bearing Sulfonamide Moiety. Castaño, L.F., J. Quiroga, R. Abonia, D. Insuasty, O.M. Vidal, R. Seña, V. Rubio, G. Puerto, M. Nogueras, J. Cobo, J. Guzman, A. Insuasty, and B. Insuasty. International Journal of Molecular Sciences, 2022. 23(20). PMID[36293443]. PMCID[PMC9604400].
[PubMed]. TB_10_2022.

5. Synthesis of New N-(3-Oxo-1-thia-4-azaspiro[4.5]decan-4-yl)pyridine-3-carboxamide Derivatives and Evaluation of Their Anti-influenza Virus and Antitubercular Activities. Cihan-Üstündağ, G., Ç. Acar, L. Naesens, G. Erköse-Genç, and D. Şatana. Archiv der Pharmazie, 2022. 355(10): e2200224. PMID[35849096].
[PubMed]. TB_10_2022.

6. Identification of 1,3-Substituted Pyrazole-based carboxamide Derivatives as Potent Antitubercular Agents. Gaikwad, N.B., S.K. Sahoo, O. Ommi, M.N. Ahmad, A. Pathan, G. Kaul, S. Nanduri, A. Dasgupta, S. Chopra, and V.M. Yaddanapudi. ChemistrySelect, 2022. 7(40): e202203333. ISI[000871736400001].
[WOS]. TB_10_2022.

7. Anti-mycobacterial Activity of Flavonoid and Pyrimidine Compounds. Garg, S., R. Kumar, D. Kunimoto, and G.R. Rayat. Molecules, 2022. 27(19): 6714. PMID[36235249]. PMCID[PMC9572476].
[PubMed]. TB_10_2022.

8. Total Synthesis and Biological Evaluation of Modified Ilamycin Derivatives. Greve, J., A. Mogk, and U. Kazmaier. Marine Drugs, 2022. 20(10): 632. PMID[36286456]. PMCID[PMC9605216].
[PubMed]. TB_10_2022.

9. Isoniazid Linked to Sulfonate esters via Hydrazone Functionality: Design, Synthesis, and Evaluation of Antitubercular Activity. Koçak Aslan, E., M. Han, V.S. Krishna, R. Tamhaev, C. Dengiz, D. Doğan Ş, C. Lherbet, L. Mourey, T. Tønjum, and M.G. Gündüz. Pharmaceuticals, 2022. 15(10): 1301. PMID[36297413]. PMCID[PMC9609273].
[PubMed]. TB_10_2022.

10. Synthesis and Biological Evaluation of Aurachin D Analogues as Inhibitors of Mycobacterium tuberculosis Cytochrome bd oxidase. Lawer, A., C. Tyler, K. Hards, L.M. Keighley, C.Y. Cheung, F. Kierek, S. Su, S.S. Matikonda, T. McInnes, J.D.A. Tyndall, K.L. Krause, G.M. Cook, and A.B. Gamble. ACS Medicinal Chemistry Letters, 2022. 13(10): p. 1663-1669. PMID[36262396]. PMCID[PMC9575164].
[PubMed]. TB_10_2022.

11. Synthesis and Antimycobacterial Screening of a Novel Series of alpha-Amino acids Containing Thiazole Linker. Nalawade, J.L., P.C. Mhaske, A.D. Shinde, A.P. Chavan, Y.K. Abhale, D. Sarkar, and V.D. Bobade. Arkivoc, 2022. 2022: pp. 64 - 72. ISI[000861679400001].
[WOS]. TB_10_2022.

12. Benzoic acid Derivatives as Prodrugs for the Treatment of Tuberculosis. Pais, J.P., M. Magalhães, O. Antoniuk, I. Barbosa, R. Freire, D. Pires, E. Valente, B. Testa, E. Anes, and L. Constantino. Pharmaceuticals, 2022. 15(9): 1118. PMID[36145340]. PMCID[PMC9502840].
[PubMed]. TB_10_2022.

13. Antibacterial Activity of Flavonoids and Triterpenoids Isolated from the Stem Bark and Sap of Staudtia kamerunensis warb. (Myristicaceae). Tonga, J.L., M.H.K. Kamdem, J.I.M. Pagna, T.Y. Fonkui, C.M. Tata, M.C.D. Fotsing, E.A. Nkengfack, E.M. Mmutlane, and D.T. Ndinteh. Arabian Journal of Chemistry, 2022. 15(10): 104150. ISI[000870760300041].
[WOS]. TB_10_2022.

14. Structure-based Optimization of Coumestan Derivatives as Polyketide Synthase 13-Thioesterase(Pks13-TE) Inhibitors with Improved hERG Profiles for Mycobacterium tuberculosis Treatment. Zhang, W., S. Lun, S.S. Wang, Y.P. Cai, F. Yang, J. Tang, W.R. Bishai, and L.F. Yu. Journal of Medicinal Chemistry, 2022. 65(19): p. 13240-13252. PMID[36174223].
[PubMed]. TB_10_2022.

15. New Rufomycins from Streptomyces atratus MJM3502 Expand anti-Mycobacterium tuberculosis Structure-Activity Relationships. Zhou, B., G. Shetye, N.M. Wolf, S.N. Chen, M. Qader, G.J. Ray, D.C. Lankin, S. Cho, J. Cheng, J.W. Suh, S.G. Franzblau, J.B. McAlpine, and G.F. Pauli. Organic Letters, 2022. 24(40): p. 7265-7270. PMID[36194676]. PMCID[PMC9588618].
[PubMed]. TB_10_2022.

Patent Citations

This month, no relevant Mycobacterium patents were identified.